EP0422011A1 - Produits a base de derives d'uracil pour stimuler la croissance et reduire la graisse chez les animaux - Google Patents

Produits a base de derives d'uracil pour stimuler la croissance et reduire la graisse chez les animaux

Info

Publication number
EP0422011A1
EP0422011A1 EP89905092A EP89905092A EP0422011A1 EP 0422011 A1 EP0422011 A1 EP 0422011A1 EP 89905092 A EP89905092 A EP 89905092A EP 89905092 A EP89905092 A EP 89905092A EP 0422011 A1 EP0422011 A1 EP 0422011A1
Authority
EP
European Patent Office
Prior art keywords
group
substituted
alkyl
phenyl
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP89905092A
Other languages
German (de)
English (en)
Inventor
Klaus Euler
Peter Lechtken
Lothar Franz
Peter Paul Hoppe
Franz-Josef Schoener
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of EP0422011A1 publication Critical patent/EP0422011A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/153—Nucleic acids; Hydrolysis products or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins

Definitions

  • the invention relates to an agent based on uracil derivatives and their use for promoting growth, increasing feed utilization and the amount of protein and for reducing fat in animals, in particular farm animals and pets.
  • feed additives to achieve higher weight additions, improved feed utilization and reduced fat intake is already widely practiced in animal nutrition, especially when fattening pigs, cattle and poultry.
  • agents comprising at least one uraci 1 derivative of the general formula I,
  • a and B either represent a hydrogen atom or together form a bond
  • D is oxygen or sulfur
  • a C 1 -C 6 alkyl group which is substituted by 1 to 3-fluorine, chlorine or bromine atoms, a hydroxy, a C 1 -C 3 alkoxy, a C 2 -C 4 alkanoyloxy, C 1 -C 3 alkylsulfonyloxy, an aminocarbonyloxy, a mono- or di (C 1 -C 3 alkyl) aminocarbonyloxy, a mercapto, a C 1 -C 3 alkyl mercapto, a phenylmercapto, a pyridylmercapto, pyridazinyl mercapto, pyrimidinyl mercapto, pyrazinyl mercapto or one Triazinyl mercapto group, a cyano, a carboxy, a (C 1 -C 4 -alkoxy) carbonyl group, a phenyl group which is formed by 1 to 2 C 1 -
  • R 6 is a hydrogen atom, a C 1 -C 4 alkyl group which is optionally substituted by a phenyl radical, a C 3 -C 6 cycloalkyl group, a phenyl group which is optionally substituted by 1 or 2 C 1 -C 4 alkyl groups, 1 or 2 C 1 -C 4 alkoxy groups or 1 or 2 halogen atoms and / or may be substituted by a nitrile, nitro or trifluoromethyl group, or
  • R 8 is a group of the formula R 8 R 9 N-, in which R 8 is a hydrogen atom or a phenyl group which is 1 to 2 times halogen atoms, C 1 -C 4 -alkyl radicals, C 1 -C 4 -alkoxy groups and / or a nitrile and / or nitro group can be substituted, R 9 represents a C 1 -C 4 alkanoyl or benzoyl group. or R 8 and R 9 together with the nitrogen atom form a benzimidazol-2-one-1-yl group, R 7 can have the same meanings as R 6 ,
  • R 10 is a C 1 -C 3 hydrocarbon radical which may be substituted by a naphthyl radical or a phenyl radical, the phenyl radical optionally 1 to 2 halogen atoms, 1 to 2 C 1 -C 4 alkyl radicals, 1 to 2 C 1 -C 4 alkoxy or a trifluoromethyl, nitro, hydroxy, C 1 -C 4 alkanyl, (C 1 -C 5 alkoxy) carbonyl and / or cyano group, a naphthyl radical, one Phenyl radical, the 1 to 3 times by halogen atoms, C 1 -C 4 alkyl radicals, C 1 -C 4 alkoxy groups and / or one Trifluoromethyl or a C 1 -C 4 alkanoyl group can be substituted, or represents a ⁇ -membered heteroaryl radical having 1 to 2 nitrogen atoms and p represents the number 2 or 3, or
  • R 11 is a hydrogen atom, a C 1 -C 8 alkyl radical, optionally by a phenyl radical, the 1 to 2 C 1 -C 4 alkyl groups, 1 to 2 C 1 -C 4 alkoxy groups and / or 1 or 2 halogen atoms may contain, is substituted, a C 3 -C 12 cycloalkyl group which may be substituted by 1 to 3 methyl groups, a phenyl or benzyl radical, or a C7-C 10 bicyclic or tricyclic alkyl radical which is substituted by 1 to 3 methyl radicals may be, or a benzo-fused C 5 -C 7 cycloalkyl group and R 12 represents a hydrogen atom or a C 1 -C 8 alkyl radical, or
  • n is the number 1, 2 or 3 and the aromatic ring can be substituted by 1 to 2 halogen atoms, 1 to 2 C 1 -C 4 alkyl radicals or 1 to 2 C 1 -C 4 alkoxy radicals, or
  • e represents a C 3 -C 6 cycloalkyl group which can be substituted by 1 to 2 C 1 -C 3 alkyl groups and / or 1 to 2 fluorine, chlorine or bromine atoms and / or by 1 phenyl group, or
  • f) represents a phenyl group which is represented by 1 to 2 C 1 -C 3 alkyl groups, 1 to 2 C 1 -C 3 alkoxy groups, 1 to 2 fluorine, chlorine or bromine atoms, an amino group, a mono- or di- C 1 -C 3 alkylamino group, a C 2 -C 4 alkanoylamino group, a carboxy group or a C 1 -C 4 alkoxycarbonyl group, or can be substituted
  • g) represents a pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl or triazinyl group which is represented by 1 to 3 C 1 -C 3 -alkyl groups and / or a C 1 -C 3 -alkoxy group, a hydroxyl group, an amino group, a Mono- or di-C 1 -C 3 alkoxy group may be substituted, or
  • h represents a 5-membered aromatic heterocyclic group which contains 1 oxygen, 1 sulfur and / or 1, 2 or 3 nitrogen atoms as heteroatoms and is optionally substituted by 1 to 3 C 1 -C 3 -alkyl groups, or
  • i) represents a C 1 -C 6 alkoxy group which is a C 3 -C 6 cycloalkyl group, one or two chlorine or bromine atoms, a C 1 -C 3 alkoxy group or a phenyl group which is substituted by 1 to 2 C 1 - C 3 alkyl, 1 to 2 C 1 -C 3 alkoxy, 1 to 2 fluorine, chlorine or bromine atoms, a trifluoromethyl radical or a nitro group may be substituted, or
  • j represents a C 3 -C 6 alkenyloxy group which may be substituted by a phenyl group, or
  • k represents a C 3 -C 6 alkynyloxy group which may be substituted by a phenyl radical, or
  • l represents a C 3 -C 6 cycloalkyloxy group which is substituted by 1 to 2 C 1 -C 3 -
  • Alkyl groups and / or 1 to 2 chlorine or bromine atoms can be substituted, or
  • n represents a C 1 -C 3 alkyl mercapto group
  • R 13 represents a hydrogen atom, a C 1 -C 3 -alkyl, a C 3 -C 4 -alkenyl or a C 3 -C 4 -alkynyl group or a phenyl group and R * ⁇ represents a hydrogen atom or a C 1 -C 3 alkyl group, or
  • R 2 represents a hydrogen atom or a C 1-3 alkyl group
  • R 1 and R 2 together form a C 2 -C 4 alkylidene group which can be substituted by 1 to 2 C 1-3 alkyl groups and / or a phenyl group,
  • R 3 and R 4 independently represent
  • a C 1 -C 6 alkyl group formed by 1 to 3-fluorine, chlorine or bromine atoms, a hydroxy, a C 1 -C 3 alkoxy, a C 2 -C 4 alkanoyloxy, a C 1 -C 3 alkylsulfonyloxy, an aminocarbonyloxy, a mono- or di (C 1 -C 3 alkyl) aminocarbonyloxy, a mercapto, a C 1 -C 3 alkyl mercapto, a phenyl mercapto , a pyridylmercapto, pyridazinyl-mercapto, pyrimidinylmercapto, pyrazinylmercapto or a triazinyl mercapto group, a cyano, a carboxy, a (C 1 -C 4 -alkoxy) carbonyl group, a phenyl group which can be substituted by 1 to 2 C 1
  • R6 is a hydrogen atom, a C 1 -C 4 alkyl group which is optionally substituted by a phenyl radical, a C 3 -C 6 cycloalkyl group, a phenyl group which is optionally substituted by 1 or 2 C 1 C 4 alkyl groups, 1 or 2 C 1 C 4 alkoxy groups or 1 or 2 halogen atoms and / or can be substituted by a nitrile, nitro or trifluoromethyl group, or
  • R 8 is a group of the formula R 8 R 9 N-, in which R 8 is a hydrogen atom or a pfienyl group which is 1- to 2-fold by halogen atoms, C 1 -C 4 alkyl-restev C 1 -C 4 alkoxy groups and / or a nitrile and / or nitro group can be substituted, R 9 represents a C 1 -C 4 alkanoyl or an 8enzimidazol-2-one-1-yl group, R 7 can have the same meanings as R 6 ,
  • R 10 is a C 1 -C 3 hydrocarbon radical which can be substituted by a naphthyl radical or a phenyl radical, the phenyl radical optionally 1 to 2 halogen atoms, 1 to 2 C 1 -C 4 alkyl radicals, 1 to 2 C 1 -C 4 alkoxy radicals or a trifluoromethyl, nitro, hydroxy, C 1 -C 4 alkanyl, (C 1 -C 5 alkoxy) carbonyl and / or cyano group, a naphthyl radical, a phenyl radical, which can be substituted 1 to 3 times by halogen atoms, C 1 -C 4 alkyl radicals, C 1 -C 4 alkoxy groups and / or a trifluoromethyl or a C 1 -C 4 alkanoyl group, or a 6-membered heteroaryl radical with 1 to 2 nitrogen atoms and p represents the number 2 or 3, or
  • R 11 is a hydrogen atom, a C 1 -C 8 alkyl radical, optionally by a phenyl radical, the 1 to 2 C 1 -C 4 alkyl groups, 1 to 2 C 1 -C 4 alkoxy groups and / or 1 to Can contain 2 halogen atoms, is substituted, a C 3 -C 12 cycloalkyl group, which can be substituted by 1 to 3 methyl groups, a phenyl or benzyl radical, or a C 7 -C 10 bi or tricyclic alkyl radical, which is substituted by 1 to 3 Methyl radicals can be substituted, or a benzo-fused
  • R 12 represents a hydrogen atom or a C 1 -C 8 alkyl radical, or
  • a 5-membered aromatic heterocyclic group which contains 1 oxygen, 1 sulfur and / or 1, 2 or 3 nitrogen atoms as hetero atoms and is optionally substituted by 1 to 3 C 1 -C 3 alkyl groups, or
  • a C 1 -C 6 alkoxy group which is a C 3 -C 6 cycloalkyl group, one or two chlorine or bromine atoms, a C 1 -C 3 alkoxy group or a phenyl group which is formed by 1 to 2 C 1 -C 3 alkyl, 1 to 2 C 1 -C 3 alkoxy, 1 to 2 fluorine, chlorine or bromine atoms, a trifluoromethyl radical or a nitro group may be substituted, or
  • a phenoxy group which can be substituted by 1 to 2 C 1 -C 3 alkyl radicals, 1 to 2 C 1 -C 3 alkoxy groups, 1 to 2 fluorine or chlorine atoms or a nitro group, or
  • R 13 represents a hydrogen atom, a C 1 -C 3 alkyl, a C 3 -C 4 alkenyl or a C 3 -C 4 alkynyl group or a phenyl group and R 14 represents a hydrogen atom or a C 1 -C 3 alkyl group;
  • a C 1 -C 6 -alkyl group which can be substituted by 1-3 fluorine, chlorine or bromine atoms, a hydroxyl, a cyano or carboxy group, c) a halogen atom, or
  • a cyano, carboxy, nitro, nitroso, hydroxyl or amino group which can be substituted by one or two C 1 -C 6 -alkyl radicals, optionally with a halogen atom or a hydroxyl group,
  • R 15 represents a hydrogen atom, a C 1-4 alkyl radical, a phenyl, a hydroxy, a C 1-4 alkoxy, a phenoxy group, the group
  • R 18 -NH-CH 2 -CH (OH) -CH 2 O- in which R 18 represents the isopropyl or tert-butyl group, a nitro, trifluoromethyl, carboxy, C 1 -C 4 alkoxycarbonyl- , Aminocarbonyl or cyano group, a fluorine, chlorine or bromine atom, an amino, C 1-4 alkylamino or di (C 1 -C 4 alkyl) amino group, a pyrrolidine, piperidine or morpholine radical, or the group -NH-CH 2 -J, where J is a pyridyl, furyl, thienyl or phenyl radical, the phenyl radical being substituted by 1 to 3 radicals from the group halogen, hydroxy, C 1 -C 4 -alkoxy) carbonyl or C 1 -C 4 alkyl may be substituted, or a group -NHL, in which L is a 5- or 6-membere
  • X and Y independently of one another represent an N atom or a carbon atom which is substituted by a hydrogen atom or one of the radicals R 19 , R 20 or R 21 , where
  • R 19 represents a hydrogen atom, a C 1 -C 4 alkyl group, a C 1 -C 4 hydroxyalkyl group, a C 1 -C 4 alkanoyl, a hydroxycarbonyl, a (C 1 -C 4 alkoxy) carbonyl -, an aminocarbonyl, a cyano group or a group of the formula purple
  • R 22 is a C 1 -C 6 alkyl, a phenyl (C 1 -C 3 alkyl), a C 1 -C 4 alkanoyl, a benzoyl, a pyridinecarbonyl or a C 1 -C 4 -Alkylsulfonyl distr means
  • R 23 represents a hydrogen atom or a C 1 -C 6 alkyl group, or
  • R 22 and R 23 together with the N atom to which they are attached represent a pyrrolidine, piperidine or piperazine residue which can be substituted by a phenyl group and / or a hydroxy group
  • R 24 represents a C 1 -C 4 alkylidene group
  • R 20 and R 21 independently of one another denote hydrogen atoms or C 1 -C 4 alkyl groups
  • Preferred compounds for the agent according to the invention and the use according to the invention are uracil derivatives of the general formula I,
  • a and B either each represent a hydrogen atom or together form a bond
  • R 1 has the following meanings: a) a hydrogen atom or
  • a C 1 -C 3 alkyl group which is substituted by a chlorine atom, a hydroxy, a methoxy, an acetoxy, a methylmercapto, a pyridiylmercapto, a cyano, a carboxy, a (C 1-4 Alkoxy) carbonyl or a phenyl group or a group of the formula Ia,
  • R6 is a hydrogen atom, a methyl group, a phenyl group which may optionally be substituted by 1 or 2 methyl, methoxy groups or chlorine atoms, or a group of the formula R 8 R * ⁇ N means in which R 8 is a hydrogen atom or a phenyl group and R * ⁇ is a propionyl or benzoyl group or R 8 and R * ⁇ together with the nitrogen atom is one Form benzimidazol-2-one-1-yl group, R 7 denotes a hydrogen atom, a methyl, a hydroxy, an acetyl, an ethoxycarbonyl or a cyano group,
  • R 10 is a benzyl, a naphthyl or a phenyl radical, which can be substituted 1 to 3 times by chlorine atoms, methyl and / or methoxy groups, or a pyridyl radical and
  • p represents the number 2
  • R 11 is a C 1 -C 3 -alkyl radical, which is optionally substituted by a phenyl radical
  • R 12 represents a hydrogen atom or a methyl radical
  • n is the number 2
  • G represents a hydrogen atom and the heterocyclic ring can be substituted by 1 to 2 C 1 -C 4 alkyl groups, or c) a C 2 -C 4 alkenyl group which can be substituted by a phenyl group, or
  • a phenyl group which can be substituted by 1 to 2 methyl groups, 1 to 2 methoxy groups, 1 to 2 chlorine atoms, a carboxy group or an ethoxycarbonyl group, or
  • a pyridyl group which can be substituted by 1 to 3 methyl groups, or
  • R 13 represents a hydrogen atom, a methyl, an allyl or a propionyl group and R 14 represents a hydrogen atom or a methyl group
  • R 2 represents a hydrogen atom
  • R 2 together form a C2 ⁇ C4 alkylidene group, which can be substituted by 1 to 2 methyl groups, R 3 and R 4 independently represent
  • R 6 is a hydrogen atom, a methyl group, a phenyl group which may optionally be substituted by 1 or 2 methyl, methoxy groups or chlorine atoms, or a group of the formula R 8 R 9 N means in which R 8 represents a hydrogen atom or a phenyl group and R 9 represents a propionyl or benzoyl group or R 8 and R 9 together with the nitrogen atom form a benzimidazol-2-one-1-yl group, R 7 represents a hydrogen atom, a Is methyl, a hydroxyl, an acetyl, an ethoxycarbonyl or a cyano group,
  • R 10 is a benzyl, a naphthyl or a phenyl radical, which can be substituted 1 to 3 times by chlorine atoms, methyl and / or methoxy groups, or a pyridyl radical and
  • p represents the number 2, or a group of the formula Ih
  • R 11 is a C 1 -C 3 alkyl radical, which is optionally substituted by a phenyl radical
  • R 12 represents a hydrogen atom or a methyl radical
  • a phenyl group which can be substituted by 1 to 2 methyl groups, 1 to 2 methoxy groups, 1 to 2 chlorine atoms, a carboxy group or an ethoxycarbonyl group, or
  • a pyridyl group which can be substituted by 1 to 3 methyl groups, or
  • R 13 represents a hydrogen atom, a methyl, an allyl or a propionyl group and R 14 represents a hydrogen atom or a methyl group;
  • a and B either each represent a hydrogen atom or together form a bond
  • R 3 and R 4 independently represent
  • R 6 is a hydrogen atom, a methyl group, a phenyl group which may optionally be substituted by 1 or 2 methyl, methoxy groups or chlorine atoms, or a group of the formula R 8 R 9 N means in which R 8 represents a hydrogen atom or a phenyl group and R 9 represents a propionyl or benzoyl group or R 8 and R 9 together with the nitrogen atom form a benzimidazol-2-one-1-yl group, R 7 represents a hydrogen atom, a Is methyl, a hydroxy, an acetyl, an ethoxycarbonyl or a cyano group,
  • R 10 is a benzyl, a naphthyl or a phenyl radical, which can be substituted 1 to 3 times by chlorine atoms, methyl and / or methoxy groups, or a pyridyl radical and
  • p represents the number 2
  • R 11 is a C 1 -C 3 alkyl radical, which is optionally substituted by a phenyl radical
  • R 12 represents a hydrogen atom or a methyl radical
  • a phenyl group which can be substituted by 1 to 2 methyl groups, 1 to 2 methoxy groups, 1 to 2 chlorine atoms, a carboxy group or an ethoxycarbonyl group, or
  • a pyridyl group which can be substituted by 1 to 3 methyl groups, or
  • R 13 represents a hydrogen atom, a methyl, an allyl or a propionyl group and R 14 represents a hydrogen atom or a methyl group;
  • a bromine or chlorine atom or d) a cyano, carboxy, nitro, nitroso, hydroxyl or amino group which can be substituted by one or two C 1 -C 3 with optionally terminal chlorine atoms or a hydroxyl group,
  • a and B either each represent a hydrogen atom or together form a bond
  • D is an oxygen atom
  • R 3 and R 4 independently represent
  • a hydrogen atom or a C 1 -C 3 -alkyl group which is formed by a chlorine atom, a hydroxy, a methoxy, an acetoxy, a methylmercapto, a pyridiylmercapto, a cyano, a carboxy, a (C 1-4 -alkoxy) carbonyl or a phenyl group or a group of the formula If,
  • R 6 is a hydrogen atom, a methyl group, a phenyl group which may optionally be substituted by 1 or 2 methyl, methoxy groups or chlorine atoms, or a group of the formula R 8 R 9 N means in which R 8 represents a hydrogen atom or a phenyl group and R 9 represents a propionyl or benzoyl group or R 8 and R 9 together with the nitrogen atom form a benzimidazol-2-one-1-yl group, R 7 represents a hydrogen atom, a Is methyl, a hydroxy, an acetyl, an ethoxycarbonyl or a cyano group,
  • R 10 is a benzyl, a naphthyl or a phenyl radical, which can be substituted 1 to 3 times by chlorine atoms, methyl and / or methoxy groups, or a pyridyl radical and
  • p represents the number 2
  • R 11 is a C 1 -C 3 alkyl radical, which is optionally substituted by a phenyl radical
  • R 12 represents a hydrogen atom or a methyl radical, or c) a C 2 -C 4 alkenyl group which can be substituted by a phenyl group, or
  • a phenyl group which can be substituted by 1 to 2 methyl groups, 1 to 2 methoxy groups, 1 to 2 chlorine atoms, a carboxy group or an ethoxycarbonyl group, or
  • a pyridyl group which can be substituted by 1 to 3 methyl groups, or
  • R 13 represents a hydrogen atom, a methyl, an allyl or a propionyl group and R 14 represents a hydrogen atom or a methyl group;
  • a 1,2,4-triazol-1-yl radical a pyrazol-1-yl radical, a pyrazol-1-yl radical or a pyrrol-1-yl radical which is substituted by a hydroxymethyl group, a formyl group , an acetyl group or a group of the formula purple,
  • R 22 denotes a C 1 -C 3 alkyl, a benzyl, a C 1 -C 4 alkanoyl or a benzoyl group,
  • R 23 represents a hydrogen atom or a C 1 -C 6 alkyl group, or
  • R 22 and R 23 together with the N atom represent a piperidine or piperazine residue which is substituted by a phenyl group
  • R 24 represents a C 1 -C 3 alkylidene group
  • the agent according to the invention is preferably in the form of animal feed, drinking water for animals, additives for animal feed and drinking water or in the form of a premix.
  • the invention also relates to the use of the uracil derivatives of the general formulas I, II and III for increasing performance in animal breeding, in particular for promoting growth, improving feed conversion, increasing the protein content and / or reducing the fat content in animals.
  • the active ingredients can be used in all areas of animal breeding as a means of promoting and accelerating growth, improving feed conversion, reducing the amount of fat and increasing the amount of protein in healthy and sick animals.
  • the effectiveness of the active ingredients is largely independent of the type and gender of the animals.
  • the active ingredients are particularly valuable in the rearing and keeping of young and fattening animals.
  • Animals in which the active ingredients can be used to promote and accelerate growth and to improve feed conversion include the following useful and ornamental animals:
  • Warm-blooded animals such as cattle, pigs, horses, sheep, goats, cats, dogs, rabbits, fur animals, e.g. Mink and chinchilla, poultry e.g. Chickens, geese, ducks, turkeys, pigeons, parrots and canaries and cold-blooded animals such as fish, e.g. Carp and reptiles, e.g. Snakes.
  • the dose of active substance which is administered to the animals in order to achieve the desired effect can be varied largely because of the favorable properties of the active substances. It is preferably about 0.01 to 100 mg of active ingredient / kg of feed, in particular 0.1 to 10 mg of active ingredient / kg of feed or drinking water.
  • the duration of administration can range from a few hours or days to several years. The appropriate amount of the active ingredient and the appropriate duration of administration depend in particular on the type, age, gender, state of health and the type of keeping and feeding the animals and are easy to determine by any specialist.
  • the active substances are administered to the animals according to the usual methods.
  • the method of administration depends in particular on the type, behavior and state of health of the animals.
  • the administration can take place orally or parenterally once or several times a day at regular or irregular intervals.
  • oral administration is preferred in most cases, in particular in the rhythm of the food and / or drink intake of the animals.
  • the active ingredients can be used as a pure mixture or in formulated form, i.e. in a mixture with non-toxic inert carriers of any kind, e.g. with carriers and in formulations as are customary in nutritional preparations.
  • the active ingredients are administered together with pharmaceutical active ingredients, mineral salts, trace elements, vitamins, protein substances, fats, colorants and / or flavorings. Oral administration together with the feed and / or drinking water is recommended, the active ingredient being added to the total amount or only parts of the feed and / or drinking water as required.
  • the active ingredients are added to the feed and / or drinking water by conventional methods by simple mixing as a pure substance mixture, preferably in finely divided form or in formulated form in a mixture with edible non-toxic carriers, optionally in the form of a premix or a feed concentrate.
  • the type of feed and its composition is irrelevant. All common or special feed compositions can be used, which preferably contain the usual balance of energy and building materials including vitamins and minerals necessary for a balanced diet.
  • the feed can be composed, for example, of vegetable substances, for example hay, beets, cereals, grain by-products, animal substances, for example meat, fats, bone meal, fish products, vitamins, for example vitamin A, D complex and B complex, proteins, amino acids, for example DL-methionine and inorganic substances such as lime and table salt.
  • vegetable substances for example hay, beets, cereals, grain by-products
  • animal substances for example meat, fats, bone meal, fish products
  • vitamins for example vitamin A, D complex and B complex
  • proteins amino acids
  • amino acids for example DL-methionine and inorganic substances such as lime and table salt.
  • Feed concentrates contain the active substances in addition to edible substances, e.g. Rye flour, corn flour, soybean flour or lime, possibly with other nutrients and building materials, as well as proteins, mineral salts and vitamins. They can be produced using the usual mixing methods.
  • edible substances e.g. Rye flour, corn flour, soybean flour or lime, possibly with other nutrients and building materials, as well as proteins, mineral salts and vitamins. They can be produced using the usual mixing methods.
  • the active ingredients can optionally also be covered by suitable agents covering their surface, e.g. protected from air, light and / or moisture with non-toxic waxes or gelatin.
  • Example 1 Example of the composition of a chick rearing feed to which an active ingredient according to the invention is added:
  • Soybean oil 3.0 5.00 Fish meal 2.9 3.00
  • Lysine 1.22% 0.51%
  • the specified feed mixtures are preferably matched for rearing and fattening chicks or pigs, but they can also be used in the same or a similar composition for rearing and fattening other animals.
  • test compounds as growth promoters and body fat reducing substances in animal nutrition - rat tests
  • the subsequent test period is 21 days.
  • the animals are fed ad libitum and / or rationed (1st week 90 g; 2nd week 110 g; 3rd week 130 g).
  • the animals are kept individually and weighed at weekly intervals.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Lesdits produits servent également à améliorer l'assimilation de la nourriture et l'absorption des protéines chez les animaux. Ils contiennent au moins un dérivé d'uracil ou un sel physiologiquement toléré dudit dérivé.
EP89905092A 1988-05-05 1989-04-29 Produits a base de derives d'uracil pour stimuler la croissance et reduire la graisse chez les animaux Withdrawn EP0422011A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3815344 1988-05-05
DE3815344 1988-05-05

Publications (1)

Publication Number Publication Date
EP0422011A1 true EP0422011A1 (fr) 1991-04-17

Family

ID=6353722

Family Applications (1)

Application Number Title Priority Date Filing Date
EP89905092A Withdrawn EP0422011A1 (fr) 1988-05-05 1989-04-29 Produits a base de derives d'uracil pour stimuler la croissance et reduire la graisse chez les animaux

Country Status (2)

Country Link
EP (1) EP0422011A1 (fr)
WO (1) WO1989010701A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0912523A1 (fr) 1996-05-21 1999-05-06 PHARMACIA & UPJOHN COMPANY Lactames de carboxylate d'aminoguanidine servant a traiter le diabete sucre non insulinodependant
DE19652431A1 (de) * 1996-12-17 1998-06-18 Bayer Ag Heterocyclyluracile
US20040242568A1 (en) 2003-03-25 2004-12-02 Syrrx, Inc. Dipeptidyl peptidase inhibitors
EP1506967B1 (fr) 2003-08-13 2007-11-21 Takeda Pharmaceutical Company Limited Inhibiteurs de dipeptidyl peptidase.
ME02005B (fr) 2005-09-14 2012-08-31 Takeda Pharmaceuticals Co Inhibiteurs de la dipeptidyl peptidase permettant de traiter le diabete
CN101360723A (zh) 2005-09-16 2009-02-04 武田药品工业株式会社 制备嘧啶二酮衍生物的方法
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
EA200971115A1 (ru) 2007-06-29 2010-04-30 Корея Рисерч Инститьют Оф Кемикал Текнолоджи Новые ингибиторы обратной транскриптазы вич
KR20100041798A (ko) 2007-06-29 2010-04-22 한국화학연구원 신규 ｈｉｖ 역전사효소 억제제
KR20100092960A (ko) 2007-12-21 2010-08-23 한국화학연구원 Ｈｉｖ 역전사 효소 억제제의 제조 방법
SG11201401531RA (en) 2011-11-11 2014-07-30 Pfizer 2-thiopyrimidinones
BR112017022340A2 (pt) 2015-05-05 2018-07-10 Pfizer 2-tiopirimidinonas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2328355A (en) * 1941-06-20 1943-08-31 Lederle Lab Inc Animal growth promoting substance
US2438353A (en) * 1943-12-08 1948-03-23 American Dairies Inc Method of controlling the growth and fattening rate of livestock and poultry and composition used in connection therewith
US2456515A (en) * 1948-01-06 1948-12-14 Thiokol Corp Animal feed composition
GB1193191A (en) * 1967-04-19 1970-05-28 Chemoforma Ag Veterinary Compositions
GB1436283A (en) * 1974-05-10 1976-05-19 Diamalt Ag Feeding-stuffs
US4239888A (en) * 1974-11-04 1980-12-16 Pfizer Inc. 1-Phenyluracils
EP0107161B1 (fr) * 1982-10-26 1989-08-09 CTA Finanz AG Moyen et procédé pour optimaliser la masse de tissu d'organes dans le domaine de la plage génétique, chez les humains et les animaux

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8910701A1 *

Also Published As

Publication number Publication date
WO1989010701A1 (fr) 1989-11-16

Similar Documents

Publication Publication Date Title
DE2413222A1 (de) Tierfuttermittel
EP0103830A2 (fr) Dérivés de phényléthylamine comme stimulateurs de croissance
DE1443560B2 (de) 3,5-bis(trifluorphenyl)-thioharnstoffe, verfahren zu ihrer herstellung und diese enthaltende futtermittel
DE2125245C3 (de) Isoflavone und Verfahren zu deren Herstellung
EP0422011A1 (fr) Produits a base de derives d'uracil pour stimuler la croissance et reduire la graisse chez les animaux
EP0119446A2 (fr) Dérivés d'aminophényléthylamine stimulant la croissance
DE2835936C3 (de) Futtermittel für Haustiere mit einem festen oder flüssigen Träger und einem Antibiotikum
EP1317187B1 (fr) Aliments ou additif alimentaire utilise comme renfor ateur de rendement ou comme agent stimulant l'appetit pour animaux
DE3234995A1 (de) Wachstumsfoerdernde phenylethylamin-derivate
DE1954226C3 (de) Verwendung eines Chinoxalinderivats als Bestandteil eines Direktfutters für Haustiere
EP0073390B1 (fr) Combinaison d'agents de kitasamycine et de chinoxaline-di-N-oxides
WO1989003181A1 (fr) Composition a base de derives de phenylpyridazinone pour assurer la croissance tout en diminuant les graisses chez les animaux
EP0142093B1 (fr) Composition dépoussiéree contenant la quinoxaline 1,4-di-N-oxyde
DE2052096A1 (de) Lactone, Verfahren zu deren Her stellung und deren Verwendung
DE3409270A1 (de) Monosilylierte aminophenylethylamin-derivate, verfahren zu ihrer herstellung und ihre verwendung zur wachstumsfoerderung
US3776904A (en) 5-nitrofurfurylidenalkyl derivatives,process for their manufacture and their use as feedstuff additives
DE2936865A1 (de) Verwendung von pikromycin-derivaten als nutritiva
DE3306159A1 (de) Wachstumsfoerdernde phenylethylamin-derivate
EP0456067A1 (fr) Quinoxalines 2,3-disubstituées comme stimulateurs de croissance animale
EP0225600A2 (fr) Procédé d'augmentation du rendement d'animaux utiles, dérivés d'aminophényléthylamines et leur préparation
EP0134444A1 (fr) 2-[N-(2-Hydroxyéthyl)-carbamoyl]-3-méthyl-quinoxaline-1,4-N-dioxyde stabilisé
DE102005063251B4 (de) Verfahren zum Herstellen eines Organo-Mineral-Düngers
DE1692405C (de) Verfahren zur Herstellung wachstumsfördernder Futtermittel und Tränkgemische
EP0002665A1 (fr) Agents bactériostatiques et leur application dans le fourrage pour animaux
DE3534421A1 (de) Verwendung von thienylaminen als leistungsfoerdernde mittel, neues thienylamin

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19901120

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19920124